JF
ASMB icon

Jump Financial’s Assembly Biosciences ASMB Stock Holding History

Jump Financial’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,917
Closed -$303K – 2019
2026
Q1 		$303K Buy
+10,917
New +$311K ﹤0.01% 1475
2022
Q1 		– Sell
-1,692
Closed -$47K – 1534
2021
Q4 		$47K Buy
+1,692
New +$55.5K ﹤0.01% 1313
2021
Q1 		– Sell
-3,008
Closed -$218K – 927
2020
Q4 		$218K Buy
+3,008
New +$353K 0.04% 739

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jump Financial's ASMB Position: Q2 2026 in Review

Jump Financial sold out of Assembly Biosciences (ASMB) in Q2 2026, closing a stake of 10,917 shares — an estimated $303K sold.

Jump Financial first reported a position in ASMB in Q4 2020 and held it in 3 quarters. The position peaked at $303K in Q1 2026. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Jump Financial reported no remaining Assembly Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 10,917 Assembly Biosciences shares in Q2 2026, an estimated $303K.
  • Jump Financial first reported a position in Assembly Biosciences in Q4 2020 and held it in 3 quarters.
  • Jump Financial's Assembly Biosciences position peaked at $303K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.